Insmed to Present at the Cowen and Company 37th Annual Health Care Conference
Feb 28, 2017 13:01 pm UTC| Business
BRIDGEWATER, N.J., Feb. 28, 2017 -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, announced today that Will Lewis, president and chief...
Jounce Therapeutics to Present at Cowen and Company 37th Annual Health Care Conference
Feb 28, 2017 13:01 pm UTC| Business
CAMBRIDGE, Mass., Feb. 28, 2017 -- Jounce Therapeutics, Inc. (NASDAQ:JNCE), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced...
Chimerix to Present at Cowen and Company 37th Annual Health Care Conference
Feb 28, 2017 13:01 pm UTC| Business
DURHAM, N.C., Feb. 28, 2017 -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company committed to discovering, developing and commercializing medicines that address significant, unmet medical needs,today announced...
DLH Awarded Substance Abuse and Mental Health Services Administration (SAMHSA) Contract
Feb 28, 2017 13:01 pm UTC| Business
ATLANTA, Feb. 28, 2017 -- DLH Holdings Corp. (NASDAQ:DLHC) (“DLH” or the “Company”), a leading provider of innovative healthcare services and solutions to Federal agencies, today announced it has been awarded the...
Feb 28, 2017 13:00 pm UTC| Business
Hollywood, Feb. 28, 2017 -- Earth Science Tech, Inc. (OTC PINK: ETST) ("ETST" or "the Company"), an innovative biotech company focused on cannabis (industrial hemp) and cannabinoid research and development,...
Horizon Pharma plc Launches RAREis™ Campaign Elevating Faces of the Rare Disease Community
Feb 28, 2017 13:00 pm UTC| Business
DUBLIN, Ireland, Feb. 28, 2017 -- Horizon Pharma plc (NASDAQ:HZNP), a biopharmaceutical company focused on improving patients’ lives by identifying, developing, acquiring and commercializing differentiated and...
Feb 28, 2017 13:00 pm UTC| Business
CAMBRIDGE, Mass., Feb. 28, 2017 -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it will present at the...